GLP-1 Peptides: Tirzepatide and Retatrutide at a Glance
tirzepatide and retatrutide differ primarily in their receptor profiles. This overview explains their similarities, differences and respective relationship to GLP-1, GIP and glucagon signalling in laboratory research.
What Are GLP-1 Peptides?
The peptides compared here show activity at the GLP-1 receptor. Tirzepatide additionally targets GIP, and retatrutide additionally targets GIP and glucagon.
The decisive difference between them: how many receptors they address at once. From two receptors to three — this is exactly what makes each of these peptides a distinct research tool.
Tirzepatide — the Dual GLP-1/GIP Agonist
Tirzepatide goes a step further and activates two receptors at once — GLP-1 and GIP. This dual action clearly distinguishes it from pure GLP-1 substances and produces an independent research profile.
In our range: Glowjaro (tirzepatide) in 10 mg, 20 mg, and 30 mg.
Retatrutide — the Triple Agonist
Retatrutide is one of the newest GLP-1 peptides and activates three receptors at once — GLP-1, GIP, and glucagon. As a triple agonist it covers the broadest receptor profile of this class and is a central tool in current metabolic research.
In our range: Glowreta (retatrutide) in 15 mg and 30 mg.
Which GLP-1 Peptide for Which Research?
In short, by receptor coverage: Glowjaro (tirzepatide) for GLP-1 + GIP, and Glowreta (retatrutide) for all three receptors.
How the receptors interact exactly is explained in the article GLP-1, GIP & Glucagon: The Receptors Explained.
Purity & Quality — Across All Three
For usable research, identity, amount and purity must be assessed separately. Only the analytical report assigned to a specific batch shows which methods and measured results are actually available. More in the article Peptide Purity.
They ship as a lyophilized powder that is reconstituted in the lab with bacteriostatic water.
GLP-1 Peptides and Batch-Specific Documentation
The catalogue lists Glowjaro (tirzepatide), and Glowreta (retatrutide). Published analytical reports apply only to the specifically identified sample or batch; shipping options are shown for the destination.
FAQ on GLP-1 Peptides
What are GLP-1 peptides?
Research peptides that act on the GLP-1 receptor. The best-known are tirzepatide and retatrutide; they differ in how many receptors they address at once.
What is the difference between tirzepatide and retatrutide?
Tirzepatide is a dual GLP-1/GIP agonist (two receptors), and retatrutide a triple agonist (GLP-1, GIP, and glucagon, three receptors).
Which GLP-1 peptide covers the most receptors?
Retatrutide, as a triple agonist, covers the three receptors of this class — GLP-1, GIP, and glucagon — the broadest receptor profile of the three.
Are GLP-1 peptides intended for human use?
No. All GLP-1 peptides mentioned here are intended exclusively for laboratory research and are not approved as medicines for human use.
Disclaimer: Research peptides are offered exclusively for research purposes. They are not intended for human use. This page provides neutral scientific orientation and does not constitute medical claims or therapeutic promises.